01/28/2025
3:15 PM | Fulcrum Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:00 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
3:50 PM | Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
12/23/2024
3:30 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:53 PM | Fulcrum Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
3:25 PM | Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:15 AM | Fulcrum Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:10 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
2:51 PM | Fulcrum Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:49 AM | Fulcrum Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for FULC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/07/2024
10:37 AM | FMR LLC (Filed by)
Fulcrum Therapeutics (Subject)
| Form SC 13G/A | |
09/24/2024
3:05 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:15 PM | Fulcrum Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2024
3:21 PM | Fulcrum Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
09/16/2024
7:21 PM | Fulcrum Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
09/12/2024
11:43 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:16 PM | Fulcrum Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
08/22/2024
3:02 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
6:55 AM | Fulcrum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/31/2024
6:10 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
6:15 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
7:00 AM | Fulcrum Therapeutics (Issuer)
Sapir Alex (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:37 PM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:10 PM | Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
11:15 PM | Fulcrum Therapeutics (Filer)
| Form EFFECT | |
03/20/2024
3:10 PM | Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2024
3:15 PM | Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:00 PM | Fulcrum Therapeutics (Subject)
Tourangeau Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
5:05 PM | Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:01 AM | Fulcrum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:53 AM | Fulcrum Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
11:08 AM | Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:44 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Fulcrum Therapeutics (Subject)
| Form SC 13G/A | |
